Sarah Buelens

3PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 21, 2021
Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study).

Sarah Buelens, Filip Poelaert, Tom Claeys

|Nov 28, 2018
Abiraterone and spironolactone in prostate cancer: a combination to avoid.

Bert Dhondt, Sarah Buelens, Jeroen Van Besien

|Aug 23, 2018
Importance of metastatic volume in prognostic models to predict survival in newly diagnosed metastatic prostate cancer.

Sarah Buelens, Elise De Bleser, Bert Dhondt

Pageof 1